返回
Scinai Immunotherapeutics Ltd（SCNI）价格
SCNI 股价走势图
SCNI 收益
Scinai Immunotherapeutics Ltd
$0.86
-4.86%
$-0.04
收盘价：Jan 16, 16:00:00 GMT-5
$0.87
0.57%
$0
盘后：Jan 16, 20:00:00 GMT-5
关键数据
前收盘价
$0.9092
开盘价
$0.954
当日区间
$0.865 - $0.963
52周范围
$0.613 - $6.18
交易量
11.3K
平均成交量
52.4K
每股收益（TTM）
0.00
股息收益率
--
市值
$2.7M
什么是 SCNI？
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The firm's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.